David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.36% |
| 2 | Consumer Discretionary | 9.47% |
| 3 | Financials | 6.95% |
| 4 | Healthcare | 6.38% |
| 5 | Communication Services | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Protolabs
PRLB
$1.85B
| $18.5M | 0.02% |
516,706
-10,610
| -2% | -$383K |
|
877
Sempra
SRE
$55.2B
| $18.4M | 0.02% |
256,725
+22,489
| +10% | +$1.61M |
|
878
Integra LifeSciences
IART
$1.29B
| $18.4M | 0.02% |
519,795
+107,938
| +26% | +$4.32M |
|
879
Coca-Cola Europacific Partners
CCEP
$48.3B
| $18.4M | 0.02% |
262,827
+92,485
| +54% | +$6.35M |
|
880
Silgan Holdings
SLGN
$4.47B
| $18.3M | 0.02% |
376,400
+288,927
| +330% | +$12.8M |
|
881
Brighthouse Financial
BHF
$2.98B
| $18.3M | 0.02% |
354,545
+252,915
| +249% | +$12.6M |
|
882
Warner Music
WMG
$14.6B
| $18.3M | 0.02% |
553,108
+343,767
| +164% | +$12M |
|
883
Cirrus Logic
CRUS
$5.57B
| $18.2M | 0.02% |
196,344
+114,703
| +140% | +$9.91M |
|
884
CALL
Sunrun
RUN
$2.21B
| $18.1M | 0.02% |
1,374,100
+859,800
| +167% | +$11.8M |
|
885
PUT
Southwest Airlines
LUV
$19.9B
| $18.1M | 0.02% |
620,200
-271,800
| -30% | -$8.41M |
|
|
JBTM
886
JBT Marel
JBTM
$6.05B
| $18.1M | 0.02% |
172,585
+5,778
| +3% | +$575K |
|
|
CYBR
887
PUT
DELISTED
CyberArk
CYBR
| $18.1M | 0.02% |
68,000
+30,500
| +81% | +$7.55M |
|
888
Fox Class B
FOX
$26.2B
| $18.1M | 0.02% |
630,970
-481,709
| -43% | -$13.5M |
|
889
Manhattan Associates
MANH
$12.3B
| $18.1M | 0.02% |
72,157
+51,621
| +251% | +$12.3M |
|
890
CALL
Macy's
M
$5.99B
| $18M | 0.02% |
902,900
+532,900
| +144% | +$10.3M |
|
891
Aon
AON
$75.3B
| $18M | 0.02% |
54,017
-104,488
| -66% | -$32.4M |
|
892
Canadian Natural Resources
CNQ
$103B
| $18M | 0.02% |
471,636
+461,036
| +4,349% | +$15.4M |
|
893
Leidos
LDOS
$17B
| $18M | 0.02% |
137,113
+27,411
| +25% | +$3.27M |
|
894
O-I Glass
OI
$1.12B
| $18M | 0.02% |
1,082,648
-124,334
| -10% | -$1.97M |
|
895
Envista
NVST
$4.37B
| $17.9M | 0.02% |
836,058
+804,311
| +2,534% | +$18.2M |
|
|
CERE
896
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $17.8M | 0.02% |
+422,015
| New | +$17.7M |
|
897
PUT
W.W. Grainger
GWW
$61.5B
| $17.8M | 0.02% |
17,500
+16,400
| +1,491% | +$15.3M |
|
898
Markel Group
MKL
$22.5B
| $17.8M | 0.02% |
11,682
-1,478
| -11% | -$2.17M |
|
899
PUT
Okta
OKTA
$22.8B
| $17.8M | 0.02% |
169,800
-105,900
| -38% | -$9.77M |
|
900
CALL
Canadian Imperial Bank of Commerce
CM
$107B
| $17.8M | 0.02% |
350,000
-342,300
| -49% | -$16.2M |
|
Similar funds
David Shaw's Q1 2024 Portfolio in Review
As of Q1 2024, David Shaw held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
David Shaw withdrew a net $8.58B in Q1 2024, closing 634 positions and reducing 1,722 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $307M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Arm worth $297M.
- David Shaw's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- David Shaw added most to Apple in Q1 2024, an estimated $820M increase.
- David Shaw's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- David Shaw fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- David Shaw's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- David Shaw opened 655 new positions and closed 634 in Q1 2024.
- David Shaw's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.